Wang, J. ., Xiong, S. ., Xie, C. ., Markesbery, W. ., & Lovell, M. . (2005). Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer’s disease. Journal of Neurochemistry, 93(4), 953-62. https://doi.org/10.1111/j.1471-4159.2005.03053.x
MA Lovell
First name:
MA
Last name:
Lovell
Lovell, M. ., Xie, C. ., & Markesbery, W. . (2000). Decreased base excision repair and increased helicase activity in Alzheimer’s disease brain. Brain Research, 855(1), 116-23. https://doi.org/10.1016/s0006-8993(99)02335-5 (Original work published 2000)
Lovell, M. ., Xie, C. ., Xiong, S. ., & Markesbery, W. . (2003). Wilms’ tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer’s disease. Brain Research, 983(1-2), 84-96. https://doi.org/10.1016/s0006-8993(03)03032-4 (Original work published 2003)
Lovell, M. ., Xie, C. ., Xiong, S. ., & Markesbery, W. . (2003). Protection against amyloid beta peptide and iron/hydrogen peroxide toxicity by alpha lipoic acid. Journal of Alzheimer’s Disease : JAD, 5(3), 229-39. https://doi.org/10.3233/jad-2003-5306
Lovell, M. ., Robertson, J. ., Buchholz, B. ., Xie, C. ., & Markesbery, W. . (1969). Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer’s disease. Neurobiology of Aging, 23(2), 179-86. https://doi.org/10.1016/s0197-4580(01)00281-0 (Original work published 1969)
Xie, C. ., Lovell, M. ., Xiong, S. ., Kindy, M. ., Guo, J. ., Xie, J. ., … Markesbery, W. . (2001). Expression of glutathione-S-transferase isozyme in the SY5Y neuroblastoma cell line increases resistance to oxidative stress. Free Radical Biology & Medicine, 31(1), 73-81. https://doi.org/10.1016/s0891-5849(01)00553-6 (Original work published 2001)
Lovell, M. ., & Markesbery, W. . (2001). Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Archives of Neurology, 58(3), 392-6. https://doi.org/10.1001/archneur.58.3.392
Lovell, M. ., Xie, C. ., & Markesbery, W. . (1969). Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures. Neurobiology of Aging, 22(2), 187-94. https://doi.org/10.1016/s0197-4580(00)00235-9 (Original work published 1969)
Lovell, M. ., Xie, C. ., & Markesbery, W. . (2000). Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radical Biology & Medicine, 29(8), 714-20. https://doi.org/10.1016/s0891-5849(00)00346-4 (Original work published 2000)
Rulon, L. ., Robertson, J. ., Lovell, M. ., Deibel, M. ., Ehmann, W. ., & Markesber, W. . (1969). Serum zinc levels and Alzheimer’s disease. Biological Trace Element Research, 75(1-3), 79-85. https://doi.org/10.1385/bter:75:1-3:79 (Original work published 1969)